EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Changes in weight secondary to improved odor perception in chronic rhinosinusitis with nasal polyps’ patients treated with Dupilumab

Cecilia Rosso, Eugenio De Corso, Anastasia Urbanelli, Gianluca Fadda, Alberto Maria Saibene, Francesco Ferella, Camilla Spanu, Carlotta Pipolo

European Archives of Oto-Rhino-Laryngology · 2025

DOI: 10.1007/s00405-024-09021-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2025. Verfasst von Cecilia Rosso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy. rosso.cecilia1@gmail.com. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Nasal Polyps, Olfactory Perception, Rhinosinusitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Milano.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The advent of biologic therapies, notably Dupilumab, has transformed therapeutic approaches to nasal polyposis. This retrospective multicentric study aimed to investigate weight changes in CRSwNP patients undergoing Dupilumab treatment and explore potential correlations with olfactory improvement.

Methods

Ninety-six patients with CRSwNP were followed for at least 12 months, with assessments including BMI (Body Mass Index), olfactory function, and disease severity.

Results

Significant increases in BMI and olfactory perception were observed after 1 year of Dupilumab treatment ( p < .001). Subgroup analysis showed that patients with hyposmia and normosmia at T12 (1-year follow up) experienced significant weight gain ( p < .001) alongside improved olfaction (both p < .001). Conversely, patients with anosmia after 1 year of therapy and also patients with stable or worsened olfaction did not show significant BMI changes (respectively p = .201 and p = .107).

Conclusion

While these findings suggest a correlation between olfactory improvement and weight gain/BMI, factors like improved nasal airflow and corticosteroid cessation under Dupilumab treatment may also influence weight in CRPwNP patients. The study highlights the need for further research to elucidate the causal relationship and long-term implications of Dupilumab-induced olfactory improvement on weight regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedNasal PolypsOlfactory PerceptionRhinosinusitisWeight GainAdultAgedFemaleHumansMaleMiddle AgedBody Mass IndexChronic DiseaseOlfaction DisordersRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

BMIBiologicsChronic rhinosinusitis with nasal polypsDupilumabHyposmiaOlfaction

Substanzen

Antibodies, Monoclonal, Humanizeddupilumab

Autor:innen und Institutionen

  • Otorhinolaryngology Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy. rosso.cecilia1@gmail.com.
  • , via Antonio di Rudinì 8, ASST Santi Polo e Carlo, Milan, Italy. rosso.cecilia1@gmail.com.
  • Otorhinolaryngology Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
  • Otorhinolaryngology Unit, Department of Surgical Sciences, University of Turin, Turin, Italy.
  • Department of Otolaryngology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, 10043, Italy.
  • Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Förderung

  • Università degli Studi di Milano

Zitieren

APA

Rosso, C., De Corso, E., Urbanelli, A., Fadda, G., Saibene, A. M., Ferella, F., Spanu, C., & Pipolo, C. (2025). Changes in weight secondary to improved odor perception in chronic rhinosinusitis with nasal polyps’ patients treated with Dupilumab. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-09021-0

Vancouver

Rosso C, De Corso E, Urbanelli A, Fadda G, Saibene AM, Ferella F, et al. Changes in weight secondary to improved odor perception in chronic rhinosinusitis with nasal polyps’ patients treated with Dupilumab. European Archives of Oto-Rhino-Laryngology. 2025. doi:10.1007/s00405-024-09021-0

BibTeX
@article{Rosso2025,
  author = {Rosso, Cecilia and De Corso, Eugenio and Urbanelli, Anastasia and Fadda, Gianluca and Saibene, Alberto Maria and Ferella, Francesco and Spanu, Camilla and Pipolo, Carlotta},
  title = {Changes in weight secondary to improved odor perception in chronic rhinosinusitis with nasal polyps’ patients treated with Dupilumab},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2025},
  doi = {10.1007/s00405-024-09021-0}
}
Kostenlos starten →